Page last updated: 2024-09-04

carbapenems and trimethoprim

carbapenems has been researched along with trimethoprim in 7 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(trimethoprim)
Trials
(trimethoprim)
Recent Studies (post-2010) (trimethoprim)
7,3551475,2776,989845894

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)trimethoprim (IC50)
Chain A, Dihydrofolate reductaseBacillus anthracis77200
Chain A, dihydrofolate reductase (DHFR)Bacillus anthracis77200
Dihydrofolate reductase Mycobacterium avium0.2588
Dihydrofolate reductaseHomo sapiens (human)1.8206
Dihydrofolate reductaseLacticaseibacillus casei0.3493
Dihydrofolate reductase type 1Escherichia coli0.25
Dihydrofolate reductaseNeisseria gonorrhoeae0.45
Thymidylate synthaseHomo sapiens (human)3.405
Dihydrofolate reductaseStaphylococcus aureus0.0875
Thymidylate synthaseEscherichia coli K-123.405
Dihydrofolate reductaseEscherichia coli K-120.6064
Bifunctional dihydrofolate reductase-thymidylate synthasePlasmodium falciparum K10.01
Dihydrofolate reductase type 1 from Tn4003Staphylococcus aureus0.023
Dipeptidyl peptidase 4Rattus norvegicus (Norway rat)2.7
Dihydrofolate reductasePneumocystis carinii0.7061
Dihydrofolate reductaseCandida albicans0.1361
Dipeptidyl peptidase 4Homo sapiens (human)2.7
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.45
Metabotropic glutamate receptor 5Rattus norvegicus (Norway rat)2.73
Mu-type opioid receptorCavia porcellus (domestic guinea pig)2.8
Bifunctional dihydrofolate reductase-thymidylate synthaseToxoplasma gondii3.2206
Bifunctional dihydrofolate reductase-thymidylate synthasePlasmodium berghei ANKA0.12
Dihydrofolate reductaseStreptococcus pneumoniae TIGR40.0297
Dihydrofolate reductaseLactococcus lactis subsp. lactis Il14030.45
Dihydrofolate reductase Bacillus anthracis4.77
Dihydrofolate reductaseRattus norvegicus (Norway rat)1.244
Dihydrofolate reductase Pneumocystis jirovecii0.092

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Curty, LK; Epp, SF; Köhler, T; Pechère, JC1
De Smet, B; Jacobs, J; Kham, C; Koole, O; Kruy, L; Lynen, L; Phe, T; Thai, S; Veng, CH; Vlieghe, E1
Dance, D1
Bao, M; Fu, Y; Li, C; Su, S; Wang, Y; Yu, L; Zhang, J; Zhang, X; Zhao, Y1
Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD1
Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K1
Aiesh, BM; Maali, Y; Omarya, S; Qandeel, F; Sabateen, A; Sholi, S; Taha, AA; Taha, SA; Zyoud, SH1

Reviews

1 review(s) available for carbapenems and trimethoprim

ArticleYear
Treatment and prophylaxis of melioidosis.
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:4

    Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Melioidosis; Sulfamethoxazole; Trimethoprim

2014

Other Studies

6 other study(ies) available for carbapenems and trimethoprim

ArticleYear
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa.
    Journal of bacteriology, 1999, Volume: 181, Issue:20

    Topics: 4-Quinolones; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Carbapenems; Chloramphenicol; Cloning, Molecular; Drug Resistance, Multiple; Gene Expression Regulation, Bacterial; Genes, Bacterial; Molecular Sequence Data; Mutation; Operon; Phenotype; Porins; Pseudomonas aeruginosa; RNA Processing, Post-Transcriptional; Sequence Analysis, DNA; Transcription, Genetic; Trimethoprim

1999
Melioidosis, phnom penh, Cambodia.
    Emerging infectious diseases, 2011, Volume: 17, Issue:7

    Topics: Adolescent; Adult; Aged; Burkholderia pseudomallei; Cambodia; Carbapenems; Cephalosporins; Diabetes Mellitus, Type 2; Diagnostic Errors; Doxycycline; Female; Humans; Male; Melioidosis; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Sulfamethoxazole; Survival Rate; Trimethoprim

2011
Outbreak of KPC-2-Producing
    Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:9

    Topics: Adhesins, Bacterial; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genome, Bacterial; Hospital Units; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neurosurgery; Plasmids; Sulfonamides; Trimethoprim; Whole Genome Sequencing

2020
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort study.
    BMC infectious diseases, 2021, Feb-08, Volume: 21, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chronic Disease; Drug Combinations; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulfadoxine; Trimethoprim; United States; Urinary Tract Infections

2021
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections

2022
Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country.
    BMC infectious diseases, 2023, Oct-02, Volume: 23, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Developing Countries; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Retrospective Studies; Sulfamethoxazole; Tertiary Care Centers; Trimethoprim

2023